(Q28343880)

English

Prostate cancer treated by anti-androgens: is sexual function preserved? EORTC Genitourinary Group. European Organization for Research and Treatment of Cancer

scientific article

In more languages

Statements

scholarly article

0 references

Prostate cancer treated by anti-androgens: is sexual function preserved? EORTC Genitourinary Group. European Organization for Research and Treatment of Cancer (English)

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

F H Schröder

1

0 references

L Collette

2

0 references

T M de Reijke

3

0 references

P Whelan

4

0 references

language of work or name

0 references

publication date

January 2000

0 references

British Journal of Cancer

0 references

82

0 references

2

0 references

283-90

0 references

Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363280

29 September 2017

Treatment of advanced prostatic cancer with parenteral cyproterone acetate: a phase III randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363280

29 September 2017

Evaluation of survival data and two new rank order statistics arising in its consideration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363280

29 September 2017

Sexual dysfunction associated with the management of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363280

2 June 2018

Are non-steroidal anti-androgens appropriate as monotherapy in advanced prostate cancer?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363280

2 June 2018

Comparison of diethylstilbestrol, cyproterone acetate and medroxyprogesterone acetate in the treatment of advanced prostatic cancer: final analysis of a randomized phase III trial of the European Organization for Research on Treatment of Cancer Urol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363280

2 June 2018

'Potency': the validation of information from a self-administered questionnaire using objective measurements of night-time erections and test-retest reliability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363280

27 November 2018

Maximum androgen blockade using LHRH agonist buserelin in combination with short-term (two weeks) or long-term (continuous) cyproterone acetate is not superior to standard androgen deprivation in the treatment of advanced prostate cancer. Final anal

1 reference

https://pubmed.ncbi.nlm.nih.gov/10646878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Flutamide versus stilboestrol in the management of advanced prostatic cancer. A controlled prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10646878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impotence in older men

1 reference

https://pubmed.ncbi.nlm.nih.gov/10646878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sexual function in the elderly

1 reference

https://pubmed.ncbi.nlm.nih.gov/10646878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10646878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intermittent androgen suppression in the treatment of prostate cancer: a preliminary report

1 reference

https://pubmed.ncbi.nlm.nih.gov/10646878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bilateral orchiectomy with or without flutamide for metastatic prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10646878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The final analysis of the EORTC Genito-Urinary Tract Cancer Co-Operative Group phase III clinical trial (protocol 30805) comparing orchidectomy, orchidectomy plus cyproterone acetate and low dose stilboestrol in the management of metastatic carcinom

1 reference

https://pubmed.ncbi.nlm.nih.gov/10646878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose bicalutamide monotherapy for the treatment of prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10646878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experience with flutamide in patients with advanced prostatic cancer without prior endocrine therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10646878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1054/BJOC.1999.0916

0 references

Dimensions Publication ID

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28343880&oldid=2175245551"